MELISSA HALLUM: Open Payments
NPI 1760924153 · TISHOMINGO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 21 payments from 9 companies in 2025. Trend: 2023 $288 · 2024 $1,089 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $63 |
| Lilly USA, LLC | 4 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novo Nordisk Inc | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 3 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, Kerendia, BREZTRI, VOQUEZNA, JOURNAVX, Ozempic.
Industry payments across OK — which companies pay providers there.
